Global GMP Cytokines Market Growth 2023-2029

Global GMP Cytokines Market Growth 2023-2029

Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well.
GMP Cytokines are intended for use in GMP manufacturing of investigational or marketed clinical products, such as cell therapy, gene therapy, tissue-engineered products and other fields.
LPI (LP Information)' newest research report, the “GMP Cytokines Industry Forecast” looks at past sales and reviews total world GMP Cytokines sales in 2022, providing a comprehensive analysis by region and market sector of projected GMP Cytokines sales for 2023 through 2029. With GMP Cytokines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GMP Cytokines industry.
This Insight Report provides a comprehensive analysis of the global GMP Cytokines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GMP Cytokines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global GMP Cytokines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GMP Cytokines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GMP Cytokines.
The global GMP Cytokines market size is projected to grow from US$ 123.8 million in 2022 to US$ 222.3 million in 2029; it is expected to grow at a CAGR of 222.3 from 2023 to 2029.
Global key players of GMP cytokines include Bio-Techne, PeproTech, CellGenix, Miltenyi Biotec, Cytiva and Lonza, etc. Top 5 players occupy for a share about 65%. North America is the largest market, with a share about 54%, followed by Europe and Asia-Pacific. In terms of product, growth factor is the largest segment, with a share about 55%. In terms of application, cell/gene therapy is the largest market, with a share over 54%.
This report presents a comprehensive overview, market shares, and growth opportunities of GMP Cytokines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
TNF
Interleukin
Growth Factor
Others
Segmentation by application
Cell/Gene Therapy
Tissue-Engineered Products
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Techne
PeproTech
CellGenix
Miltenyi Biotec
Cytiva
Lonza
ReproCELL
Sino Biological
Akron Biotech
Creative Bioarray
Key Questions Addressed in this Report
What is the 10-year outlook for the global GMP Cytokines market?
What factors are driving GMP Cytokines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GMP Cytokines market opportunities vary by end market size?
How does GMP Cytokines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.